Intestinal Ultrasound Feasible for Detecting Pediatric Inflammatory Bowel Disease
By Lori Solomon HealthDay Reporter
FRIDAY, Jan. 3, 2025 -- Intestinal ultrasound (IU) can be considered a screening tool for pediatric inflammatory bowel disease (IBD), according to a study published online Dec. 24 in the Journal of Pediatric Gastroenterology and Nutrition.
Hamza Hassan Khan, M.D., from the Medical University of South Carolina in Charleston, and colleagues compared IU findings to clinical disease, fecal calprotectin (FC), and endoscopic findings in newly diagnosed pediatric IBD patients. The analysis included 50 pediatric patients (median age, 13.5 years) undergoing colonoscopy (50 percent with IBD).
The researchers found that IU sensitivity was 76 percent, specificity 84 percent, positive predictive value 83 percent, and negative predictive value 78 percent for diagnosing IBD. For detection of moderate-to-severe disease, performance was 91.3, 86.21, 84.0, and 92.6 percent, respectively. There was a significant correlation seen between IU and FC, the Mayo score, and Simple Endoscopic Score (0.513, 0.565, and 0.731, respectively). Pearson correlations for the Pediatric Ulcerative Colitis Activity Index and Pediatric Crohn's Disease Activity Index scores were 0.070 and −0.159, respectively.
"IU can be considered a screening tool for pediatric IBD," the authors write. "Larger multicenter studies are needed in pediatrics to establish pediatric-specific scoring systems and support responses to treatment algorithms."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
AAP Updates Screening Guidance for Child Mental Health, Behavioral Problems
MONDAY, Aug. 25, 2025 -- In a clinical report issued by the American Academy of Pediatrics and published online Aug. 25 in Pediatrics, updated recommendations are presented for...
Discordance Seen Between Care Goals, Treatment Intent in Advanced Cancer
MONDAY, Aug. 25, 2025 -- More patients with advanced cancer report that their treatment discordantly focuses on longevity over comfort than patients with other illnesses...
Apitegromab Improves Motor Function in Spinal Muscular Atrophy
MONDAY, Aug. 25, 2025 -- For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhibits myostatin activation, improves...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.